Barcelona, Spain · Founded 2005 · Privately Held (backing)
Developer of adenosine receptor modulators designed to advance treatments for orphan and neurological diseases. Palobiofarma is based in Barcelona, Spain and was founded in 2005. Its last known valuation is $79.3 million. It has raised $21.1 million.
Last price · $/share
—
Implied valuation
$79.3M
Total raised
$21.1M
Last round
—
Cap table — not yet on record
Palobiofarma's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Palobiofarma with a free account
·The complete investor list: 15 names
·Watch Palobiofarma: the Monday email on marks, rounds and moves
